Description
Listing of 9,987,258 equity shares of Vineet Laboratories Limited issued on rights basis at Rs. 10/- each with premium of Rs. 20/-, effective February 5, 2026.
Summary
BSE has approved the listing of 9,987,258 new equity shares of Vineet Laboratories Limited (Scrip Code: 543298) issued on a rights basis. The shares are listed and permitted to trade on the Exchange from February 5, 2026. These shares were allotted on February 2, 2026, at a face value of Rs. 10/- each with a premium of Rs. 20/-, and rank pari-passu with existing equity shares.
Key Points
- 9,987,258 equity shares of Rs. 10/- each issued at premium of Rs. 20/-
- Issued on rights basis to existing shareholders
- ISIN: INE505Y01010
- Distinctive Numbers: 9219009 to 19206266
- Date of Allotment: February 2, 2026
- Shares rank pari-passu with existing equity shares
- Scrip Code: 543298
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members of BSE are informed about the listing and are permitted to trade these new securities effective from the listing date.
Important Dates
- Date of Allotment: February 2, 2026
- Trading Commencement Date: February 5, 2026 (Thursday)
- Circular Issue Date: February 4, 2026
Impact Assessment
This is a routine corporate action with limited market impact. The rights issue increases the outstanding share capital of Vineet Laboratories Limited by approximately 10 million shares. The new shares carry the same rights and privileges as existing shares. Impact is limited to shareholders and traders of this specific security, with no broader market or regulatory implications.
Impact Justification
Routine listing of rights issue shares for a single company with no broader market implications